Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: Results from the BELA trial

Jorge E. Cortes, Dong Wook Kim, Hagop M. Kantarjian, Tim H. Brümmendorf, Irina Dyagil, Laimonas Griskevicius, Hemant Malhotra, Christine Powell, Karïn Gogat, Athena M. Countouriotis, Carlo Gambacorti-Passerini

Research output: Contribution to journal › Article › peer-review